Condition: Gestational Diabetes · Pregnancy Related · Sponsor: Thomas Jefferson University
The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a Strict and permissive threshold. The Strict study arm target range will be 65-120 mg/dL, with time in range goal of 70%. The permissive study arm target range will be 65-140 mg/dL, with target time in range goal of 70%.
This description comes directly from the study's public registry record.
Kavisha Khanuja, MD · 2159555000 · kxk334@jefferson.edu
Rodney McLaren Jr, MD · 2159555000 · rodney.mclaren@jefferson.edu
Always discuss trial participation with your own doctor first.
| University of Rochester Medical Center | Rochester, New York, United States | Not Yet Recruiting |
| Thomas Jefferson University | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06419803